Research
Print page Print page
Switch language
Hvidovre Hospital - a part of Copenhagen University Hospital
Published

Guideline for the management of COVID-19 patients during hospital admission in a non-intensive care setting

Research output: Contribution to journalReviewpeer-review

  1. The Danish severe asthma register: an electronic platform for severe asthma management and research

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Automatic oxygen titration with O2matic® to patients admitted with COVID-19 and hypoxemic respiratory failure

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Inspiratory muscle strength and walking capacity in patients with COPD

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Lung Ultrasound to Phenotype Chronic Lung Allograft Dysfunction in Lung Transplant Recipients. A Prospective Observational Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Behandling af indlæggelseskrævende COVID-19

    Research output: Contribution to journalReviewpeer-review

  4. Udredning og opfølgning af indlæggelseskrævende COVID-19

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Introduction: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has presented health-care systems worldwide with novel challenges and experiences and evidence is emerging during the pandemic. Patients requiring hospitalization frequently suffer from respiratory failure of different severities.

Aim: The aim of this guideline is the treatment of patients with SARS CoV-2 (COVID-19) in hospital; in particular, it addresses the treatment of respiratory failure treated in general Internal Medical- and Pulmonary Medical wards.

Results: Elderly patients and patients with chronic disease are particularly vulnerable to COVID-19. Target oxygen saturation should be between 92% and 96% in patients without chronic lung diseases. Treatment with >5 L oxygen/min should be in close collaboration with intensive care colleagues and >15 l/min preferably in intensive care units. High-flow nasal canula (HFNC) and long-term Continuous Positive Airway Pressure (CPAP) are recommended for patients not responding to conventional oxygen therapy. Non-invasive ventilation (NIV) is only recommended for selected patients, such as those with a ceiling of treatment or patients presenting with hypercapnic failure. With the use of humidification protective equipment as FFP2-3 masks should be used. Nebulized medication should be avoided, and spacers should be used instead.

Conclusion: Respiratory failure is frequently the cause of hospitalization in patients with COVID-19 and should be monitored closely.

Original languageEnglish
JournalEuropean Clinical Respiratory Journal
Volume7
Issue number1
Pages (from-to)1761677
ISSN2001-8525
DOIs
Publication statusPublished - 28 May 2020

    Research areas

  • Guideline, SARS-CoV-2, COVID-19, corona virus, hospital, oxygen, NIV, CPAP, HFNC, high Flow

ID: 61307978